Biomarkers of HPV in head and neck squamous cell carcinoma.
about
Human Papilloma Virus Associated Squamous Cell Carcinoma of the Head and NeckEpidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell CarcinomaAn updated overview of HPV-associated head and neck carcinomasDetection of HPV infection in head and neck squamous cell carcinoma: a practical proposalNovel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinomaSerum biomarkers of polyomavirus infection and risk of lung cancer in never smokersPrognostic Significance of Glutathione Peroxidase Levels (GPx1) in Head and Neck Cancers.A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods.Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.High-risk HPV types and head and neck cancer.Combined P16 and human papillomavirus testing predicts head and neck cancer survival.Human papillomavirus serology and tobacco smoking in a community control group.Obesity and head and neck cancer risk and survival by human papillomavirus serology.Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirusThe clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.Current trends in the etiology and diagnosis of HPV-related head and neck cancers.Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle.HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.Alcohol and Tobacco Increases Risk of High Risk HPV Infection in Head and Neck Cancer Patients: Study from North-East Region of India.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesSystemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.CpG island methylation profile in non-invasive oral rinse samples is predictive of oral and pharyngeal carcinoma.Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas.Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-SeqInhibition of mTOR reduces anal carcinogenesis in transgenic mouse modelEvidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma.Adequacy of fine-needle aspiration specimens for human papillomavirus infection molecular testing in head and neck squamous cell carcinomaTumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer.The immune response in HPV(+) oropharyngeal cancer.Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma.Impact of HPV infection on oral squamous cell carcinoma.The interplay between HPV and host immunity in head and neck squamous cell carcinoma.PET imaging biomarkers in head and neck cancer.Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.
P2860
Q26781385-78EA6555-73D9-4699-9598-12DBDA474CE0Q26782499-DE459D41-1BCC-4730-8DB0-196526661F9DQ27014019-393272FC-CAB5-4FF8-B913-26FA5E9D7262Q28287388-9B670F12-F2C0-402C-8F86-1C937BC481EFQ28383468-7C66F042-0C10-468F-AA79-BD0AD4BD8341Q28394577-3D0C44D6-D2DF-4D7A-A1E9-FAE127214593Q33652692-B8C0D9A9-908D-4181-982B-444368CF6670Q33679518-6A0F60C8-CE24-454C-BC25-AD863DD83221Q33726331-AEB2D8C3-89C1-43AF-8EEE-1BB83476D49CQ33770030-C185998B-86D3-41C4-BDE9-901155FEBB10Q33934499-ED654D4C-24CD-437A-849A-BF67B8B9D113Q34156725-A604CCD5-648C-47BD-A4AF-D30054519BE2Q34976629-286535DA-37BD-4838-88A5-B3DBF11F6E59Q34998853-634ECCAC-5882-4231-A746-1BA778EE1035Q35109451-D90CF1E7-9A4A-4703-9F4D-DC34BD4E691FQ35344832-1166AF4A-5E89-41FE-9AEE-CA9EDEC5C0A2Q35469459-810DFE25-1F66-4D53-B4C5-A6D03FE11067Q35582737-0AD71B77-FF2F-40A4-8E19-BE7D710BB65BQ35688600-C9AD483F-9D50-4C9A-B880-8F3B3B11DF99Q35810101-D87AB74D-551E-4B54-8447-9F1199579846Q35838231-B5094274-3C3F-44B6-BC24-E15E95562E59Q35927872-948D684C-CDB1-44F5-B2B1-0D3A03EE1BBCQ36074308-1A0A1D02-3D80-4416-ADD9-50BB44F60407Q36100833-CB86CD85-53BF-45FE-B3E2-3E8FD303DAABQ36344111-4E225EFF-1B60-4362-B53A-795D12FC9549Q36830344-57F01354-97E0-4343-AFD7-F2BD5EE0D6ABQ37003406-F430A45D-6782-42BA-921E-A35C35CF4440Q37123281-232980B9-C01B-4D83-A0A6-A1854604AD54Q37215789-324F2C9F-8D7E-44E2-8C5E-74E32E39C57AQ37348338-E19621CE-9FE6-47AB-9048-D02E003FDE1BQ37407758-F60D7C6D-E802-48CA-BD54-7E11FB6E10CCQ37507336-CE310275-2BC7-41B9-B46E-E9A8BA3C1A7CQ37562953-D680D609-3CF7-4B8C-9886-C00682BBDF69Q37631295-5194802A-6E1A-4873-9334-479D4683F89AQ37636535-273CCDBA-4633-4D14-9C53-771605FFBF17Q37709093-C597EC1C-7048-48D8-AE64-ABAB478C2268Q37718270-9DDC1577-B96C-426E-9063-3BC48CE93EABQ38126455-FFC37A2B-AC20-46A9-A4BF-61C1ED3960DDQ38312362-49229485-6288-4EC5-A738-AF2AAAD55B32Q38557897-1AA186E7-2A92-456F-9C4F-27821A24B240
P2860
Biomarkers of HPV in head and neck squamous cell carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Biomarkers of HPV in head and neck squamous cell carcinoma.
@ast
Biomarkers of HPV in head and neck squamous cell carcinoma.
@en
type
label
Biomarkers of HPV in head and neck squamous cell carcinoma.
@ast
Biomarkers of HPV in head and neck squamous cell carcinoma.
@en
prefLabel
Biomarkers of HPV in head and neck squamous cell carcinoma.
@ast
Biomarkers of HPV in head and neck squamous cell carcinoma.
@en
P2093
P2860
P50
P1433
P1476
Biomarkers of HPV in head and neck squamous cell carcinoma
@en
P2093
Brock C Christensen
Caihua Liang
Gordana Halec
Jeffrey F Krane
John R Clark
Karl T Kelsey
Richard O Wein
Robert I Haddad
Tim Waterboer
P2860
P304
P356
10.1158/0008-5472.CAN-11-3277
P407
P577
2012-09-18T00:00:00Z